Why Founder Selling After an IPO Lockup Isn't a Red Flag

A founder cashes out tens of millions of dollars of stock a few months after taking the company public, and the headlines write themselves: is the person who knows the business best heading for the exit? Most of the time, the answer is no. Selling in the quarters after an IPO lockup expires is one of the most predictable and least sinister events in insider data — and knowing how to read it will stop you from mistaking a founder's financial planning for a warning about the business.

What an IPO lockup is, and why selling follows it

When a company goes public, insiders and pre-IPO investors typically agree to a lockup — usually around 180 days — during which they cannot sell. Until that point, a founder's wealth is almost entirely trapped in a single, illiquid, undiversified asset. The day the lockup lifts is the first realistic opportunity to convert some of that paper into cash. A wave of insider sales in the first few quarters after a lockup expires is therefore the norm, not a signal — it is the mechanical release of years of accumulated equity.

The relevant comparison is not "did the founder sell?" but "how much did they sell relative to what they still own?" A founder trimming a sliver of a controlling stake is diversifying; a founder unloading the bulk of their position quarter after quarter is a different story. The first number tells you almost nothing alarming; the second is worth attention.

How to check the retained stake

Before reacting to a post-IPO sale, find out what the insider kept. Three places tell you:

• The Form 4 shares-owned-after figure — but read it carefully, because for founders it often shows only directly held common stock and excludes shares held through trusts or other classes.
• Schedule 13D/G filings — these report beneficial ownership above 5% and capture the full economic stake, including shares the Form 4 line may understate.
• Form 4 Table II — derivative and indirect holdings (options, Class B, trusts) that sit outside the directly held common-stock line.

Consider CoreWeave, the AI cloud company that went public in 2025. Co-founder Brannin McBee sold roughly $32 million of stock in a single block in April 2026 — a large-sounding number. But his most recent Schedule 13G reported about 4.1% beneficial ownership, roughly 16.5 million shares, plus additional derivative holdings. The sale was a small fraction of a still-substantial stake. Read against the retained ownership, it is diversification, not an exit.

The other clues: cadence and structure

Two more details separate routine selling from a real warning. First, cadence: a steady, evenly spaced program — especially one executed under a prearranged Rule 10b5-1 plan adopted in advance — signals scheduled diversification rather than a reaction to bad news. A sudden, one-off dump outside any pattern is more notable. Second, structure: founders of dual-class companies often convert high-vote shares to common stock and sell only the converted slice, leaving their control block — and the bulk of their economic interest — untouched.

This pattern is not unique to brand-new IPOs. Even years after going public, founders run steady selling programs while retaining control. Matthew Prince of Cloudflare has sold on a regular schedule for years while remaining a greater-than-5% beneficial owner — the same convert-and-diversify logic, just further from the IPO. In both the new-listing and mature cases, the retained stake is the number that matters.

When post-IPO selling is worth worrying about

Routine does not mean always benign. The cases that warrant attention share features: the founder sells a large share of their total holdings rather than a sliver; multiple insiders sell heavily in the same window; the selling accelerates around — or just before — disappointing news; or it happens outside any disclosed plan. None of those describe a founder converting a small portion of a controlling stake on a schedule. The discipline is to measure the sale against the retained position and the cadence before deciding it means anything at all.

FAQ

What is an IPO lockup period?
It is a period after a company goes public — typically around 180 days — during which insiders and pre-IPO investors agree not to sell their shares. When it expires, insiders can sell for the first time, which often produces a wave of routine selling.

Is it bad when a founder sells stock after an IPO?
Usually not. Before the lockup lifts, a founder's wealth is locked in a single illiquid asset, so selling a portion afterward is normal diversification. What matters is how much they sold relative to how much they still own.

How do I tell routine diversification from a real warning?
Check the retained stake (via Form 4, Schedule 13D/G, and Table II), the cadence (steady or plan-driven versus a sudden dump), and whether multiple insiders are selling or the timing precedes bad news.

Why doesn't the Form 4 shares-owned figure tell the whole story for founders?
It often shows only directly held common stock and excludes shares held through trusts, other share classes, or derivatives. Schedule 13D/G and Form 4 Table II capture the fuller beneficial stake.

What is a 10b5-1 plan and why does it matter here?
It is a prearranged trading plan adopted in advance that sells shares on a fixed schedule. Sales executed under such a plan signal scheduled diversification rather than a reaction to news, which is why a steady cadence is reassuring.

When should post-IPO founder selling actually concern me?
When a founder sells a large share of their total holdings rather than a sliver, when several insiders sell heavily at once, when selling accelerates before disappointing news, or when it happens outside any disclosed plan.